Clinical Study

Risk Factor Analysis and Microbial Etiology of Surgical Site Infections following Lower Segment Caesarean Section

Table 2

(a) Resistance pattern in Gram-positive organisms (in %). (b) Resistance pattern in Gram-negative organisms (in %).
(a)

Org.VPMEAtCTGCoCpCuAcAm

S. aureus 066.723.815.814.2866.6728.62544.456.2564.335.746.7
Enterococcus spp.05010000066.75010000%0
CONS016.6016.670000601006066.67

V: vancomycin, P: penicillin, E: erythromycin, At: azithromycin, C: chloramphenicol, T: tetracycline, G: gentamicin, Co: cotrimoxazole, Cp: cephalexin, Ac: amoxicillin-clavulanic acid, and Am: amoxicillin.
(b)

Org.AkCfCiCeCoAsAIAcNtScPbCaAo

E. coli 14.2812.520.814.2861.95064.7038.533.300060
Kleb. spp.16.6716.6733.3072.25.50000000
C.  freundii 25075050066.70000000
P.  vulgaris 000000000000100100
Ps. aeruginosa 014.2814.281000000000000
Acineto. spp.36.5831.768.2981.867.69.391.6700092018.750

Ak: amikacin, Cf: ciprofloxacin, Ci: ceftriaxone, Co: cotrimoxazole, As: ampicillin-sulbactam, A: ampicillin, I: imipenem, Ac: amoxicillin-clavulanic acid, Nt: netilmicin, Sc: sparfloxacin, Pb: polymyxin b, Ca: ceftazidime, and Ao: aztreonam.